142 related articles for article (PubMed ID: 12543666)
1. Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.
Kamai Y; Kubota M; Fukuoka T; Kamai Y; Maeda N; Hosokawa T; Shibayama T; Uchida K; Yamaguchi H; Kuwahara S
Antimicrob Agents Chemother; 2003 Feb; 47(2):601-6. PubMed ID: 12543666
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Spreghini E; Maida CM; Tomassetti S; Orlando F; Giannini D; Milici ME; Scalise G; Barchiesi F
Antimicrob Agents Chemother; 2008 Jun; 52(6):1929-33. PubMed ID: 18391037
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
[TBL] [Abstract][Full Text] [Related]
5. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
[TBL] [Abstract][Full Text] [Related]
6. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Najvar LK; Correa A; James P; Luther MF; Graybill JR
J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961
[TBL] [Abstract][Full Text] [Related]
7. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
[TBL] [Abstract][Full Text] [Related]
9. VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
Break TJ; Desai JV; Healey KR; Natarajan M; Ferre EMN; Henderson C; Zelazny A; Siebenlist U; Yates CM; Cohen OJ; Schotzinger RJ; Perlin DS; Garvey EP; Lionakis MS
J Antimicrob Chemother; 2018 Aug; 73(8):2089-2094. PubMed ID: 29788070
[TBL] [Abstract][Full Text] [Related]
10. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.
Pfaller MA; Diekema DJ; Sheehan DJ
Clin Microbiol Rev; 2006 Apr; 19(2):435-47. PubMed ID: 16614256
[TBL] [Abstract][Full Text] [Related]
11. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
[TBL] [Abstract][Full Text] [Related]
12. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Andes D; Marchillo K; Stamstad T; Conklin R
Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026
[TBL] [Abstract][Full Text] [Related]
14. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole and fluconazole susceptibility of Candida isolates.
Pelletier R; Loranger L; Marcotte H; DE Carolis E
J Med Microbiol; 2002 Jun; 51(6):479-483. PubMed ID: 12018654
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
Kamai Y; Harasaki T; Fukuoka T; Ohya S; Uchida K; Yamaguchi H; Kuwahara S
Antimicrob Agents Chemother; 2002 Feb; 46(2):367-70. PubMed ID: 11796343
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
Petraitis V; Petraitiene R; Kelaher AM; Sarafandi AA; Sein T; Mickiene D; Bacher J; Groll AH; Walsh TJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3959-67. PubMed ID: 15388459
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole versus Candida albicans: a complex relationship.
Graybill JR; Montalbo E; Kirkpatrick WR; Luther MF; Revankar SG; Patterson TF
Antimicrob Agents Chemother; 1998 Nov; 42(11):2938-42. PubMed ID: 9797229
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
Rodríguez-Tudela JL; Almirante B; Rodríguez-Pardo D; Laguna F; Donnelly JP; Mouton JW; Pahissa A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2007 Oct; 51(10):3599-604. PubMed ID: 17646421
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of D0870 treatment of experimental Candida vaginitis.
Fidel PL; Cutright JL; Sobel JD
Antimicrob Agents Chemother; 1997 Jul; 41(7):1455-9. PubMed ID: 9210665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
